MedicationsComments Off on Baricitinib and Remdesivir Combination Receives Emergency Use Authorization from the FDA for the Treatment of Hospitalized Patients with COVID-19
MedicationsComments Off on Fulcrum Therapeutics Receives Orphan Drug Designation for Losmapimod in Facioscapulohumeral Muscular Dystrophy (FSHD) and Announces Expanded Patent Portfolio
MedicationsComments Off on Oryzon Receives Approval to Start CLEPSIDRA: a Phase IIa Clinical Trial in Small Cell Lung Cancer with Iadademstat (ORY-1001)
We and our partners use cookies on this site to improve our service, perform analytics, personalize advertising, measure advertising performance, and remember website preferences.Ok